Difference between revisions of "Part:BBa K2794001"

Line 38: Line 38:
  
 
'''CD63-Forward:''' CCCAAGCTTATGGCGGTGGAAGGAGGAA
 
'''CD63-Forward:''' CCCAAGCTTATGGCGGTGGAAGGAGGAA
 +
 
'''CD63-Reverse:''' GCTCTAGACATCACCTCGTAGCCACTTCTGAT
 
'''CD63-Reverse:''' GCTCTAGACATCACCTCGTAGCCACTTCTGAT
  
Line 43: Line 44:
  
 
'''Vhb-Forward:''' CGGGATCCTTTACAGCTAGCTCAGTCCTAGGTATTATG
 
'''Vhb-Forward:''' CGGGATCCTTTACAGCTAGCTCAGTCCTAGGTATTATG
 +
 
'''Vhb-Reverse:''' CGGAATTCTTATTCTGCATCCTGTGCATACAGA
 
'''Vhb-Reverse:''' CGGAATTCTTATTCTGCATCCTGTGCATACAGA
  

Revision as of 08:47, 7 October 2018


CD63 Varient 1 (Homo Sapiens)

CD63 Varient 1 (Homo Sapiens)
Function Exosome Membrane Anchoring
Use in Mammalian cells
RFC standard RFC 10 compatible
Backbone pSB1C3
Submitted by [http://2018.igem.org/Team:SHSU_China SHSU_China]

Overview

CD63 is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth, and motility. This encoded protein is a cell surface glycoprotein that is known to complex with integrins. It may function as a blood platelet activation marker.

CD63 (varient 1) passes through the membrane 4 times. The N- and C- terminus is both located inside the membrane. The protein has two extracellular cringle (EC1, EC2) and one intracellular loop (IL), with EC2 significantly longer than EC1 and carries main cellular functions.

T--SHSU China--CD63 hand.png

Figure 1: Structure of CD63

CD63 is recently researched and used in the field of extracellular vesicle (EVs) research. Due to its strong bond on EVs, it is used in exosome identification, extraction and targeted therapy. A protein sequence can be attached to either the N- or C- terminus so that a protein cargo can be loaded into exosomes. This method is refereed as membrane protein anchoring. There's also research using modified CD63 which has N- terminus out of membrane so that a signal peptide can be attached to the N- terminus for targeted protein therapy using exosomes.

Design

Using CD63 to load protein into exosomes requires making a fusion protein sequence in a mammalian vector backbone. Team SHSU_China used pRK7-N-FLAG as their vector backbone because the FLAG tag at the N-terminus can be used in western blot and further conformation that the protein cargo is inside the membrane. The fusion protein required a stop-codon-removed CDS, so the following primer is used:

CD63-Forward: CCCAAGCTTATGGCGGTGGAAGGAGGAA

CD63-Reverse: GCTCTAGACATCACCTCGTAGCCACTTCTGAT

The HindIII and XbaI sites in MCS are used to subclone CD63 into the vector. In team SHSU_China's project, CD63 is used to load Vitreoscilla hemoglobin (vhb) into exosomes, so another pair of primers is used to clone Vhb from pSB1C3:

Vhb-Forward: CGGGATCCTTTACAGCTAGCTCAGTCCTAGGTATTATG

Vhb-Reverse: CGGAATTCTTATTCTGCATCCTGTGCATACAGA

BamHIand EcoRI sites are used to subclone targeted sequence into the vector to form the CD63-Vhb fusion protein.

T--SHSU China--PNCV.png

Figure 1: pRK7-N-FLAG-CD63-Vhb (PNCV)

Prove of Expression

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]

References